Autoantibodies to glutamate decarboxylase in a patient with cerebellar cortical atrophy, peripheral neuropathy, and slow eye movements.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Archives of Neurology

• Publication date

  1995-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHNEUR.1995.00540290050017PMID 7733840
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological properties of the postsynaptic inhibition by Purkinje cell axons and the action of γ-aminobutyric acid on Deiters neurones

  2004cited by this paper
• Cerebellar excitatory and inhibitory amino acid receptors in multiple system atrophy

  1993cited by this paper
• Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes.

  1993cited by this paper
• Heterogeneity of autoantibodies in stiff‐man syndrome

  1993cited by this paper
• Clinical features and classification of inherited ataxias.

  1993cited by this paper
• Pathogenesis of central nervous system paraneoplastic syndromes.

  1992cited by this paper
• Transient expression of GABA immunoreactivity in the developing rat spinal cord

  1992cited by this paper
• Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of Type 1 (insulin-dependent) diabetes mellitus in high risk individuals

  1992cited by this paper
• Paraneoplastic cerebellar degeneration.

  1992cited by this paper
• Distinct cytoplasmic islet cell antibodies with different risks for Type 1 (insulin-dependent) diabetes mellitus

  1992cited by this paper
• GABA and pancreatic beta‐cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic‐like microvesicles suggests their role in GABA storage and secretion.

  1991cited by this paper
• Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies.

  1991cited by this paper
• HuD, a paraneoplastic encephalomyelitis antigen, contains RNA-binding domains and is homologous to Elav and Sex-lethal.

  1991cited by this paper
• Messenger molecules in the cerebellum.

  1990cited by this paper
• Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome.

  1990cited by this paper
• Presence of an autoantibody against a Golgi cisternal membrane protein in the serum and cerebrospinal fluid from a patient with idiopathic late onset cerebellar ataxia.

  1988cited by this paper
• Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus.

  1988cited by this paper
• Improvement of cerebellar ataxia with levorotatory form of 5-hydroxytryptophan. A double-blind study with quantified data processing.

  1988cited by this paper
• Paraneoplastic cerebellar degeneration: Clinical‐immunological correlations

  1988cited by this paper
• Monoclonal antibodies to glutamic acid decarboxylase.

  1986cited by this paper
• Studies on neurotransmitter markers and neuronal cell density in the cerebellar system in olivopontocerebellar atrophy and cortical cerebellar atrophy.

  1985cited by this paper
• GABA influences the ultrastructure composition of cerebellar granule cells during development in culture

  1984cited by this paper
• Neurological disorders associated with deficiency of glutamate dehydrogenase

  1984cited by this paper
• Glutamate dehydrogenase deficiency in patients with olivopontocerebellar atrophy

  1983cited by this paper
• Antibodies to cerebellar Purkinje cells in patients with paraneoplastic cerebellar degeneration and ovarian carcinoma

  1983cited by this paper
• Immunohistochemical studies of the GABA system in the pancreas.

  1983cited by this paper
• Cerebrospinal fluid GABA levels in various neurological and psychiatric diseases.

  1982cited by this paper
• Cerebrospinal fluid gamma-aminobutyric acid variations in cerebellar ataxia.

  1982cited by this paper
• [Regression of the cerebellar syndrome under long-term administration of 5-HTP or the combination of 5-HTP and benserazide. 26 cases quantified and treated using computer methods].

  1982cited by this paper
• CEREBROSPINAL FLUID γ-AMINOBUTYRIC ACII VARIATIONS IN CEREBELLAR ATAXIA

  1982cited by this paper
• Effect of GABA-Administration on murine neuroblastoma cells in culture

  1981cited by this paper
• "Idiopathic" late onset cerebellar ataxia. A clinical and genetic study of 36 cases.

  1981cited by this paper
• Immunocytochemical localization of glutamate decarboxylase in rat cerebellum with a new antiserum.

  1981cited by this paper
• [Regression of human cerebellar ataxia under long term administration of 5-hydroxytryptophan].

  1981cited by this paper
• Early onset cerebellar ataxia with retained tendon reflexes: a clinical and genetic study of a disorder distinct from Friedreich's ataxia.

  1981cited by this paper
• Glutamate dehydrogenase deficiency in three patients with spinocerebellar syndrome

  1980cited by this paper
• Levels of γ-Aminobutyric Acid in Cerebrospinal Fluid in Various Neurologic Disorders

  1980cited by this paper
• High concentration of GABA and high glutamate decarboxylase activity in rat pancreatic islets and human insulinoma.

  1976cited by this paper
• Cerebellar Cortex

  1974cited by this paper
• A new form of heredo-familial spinocerebellar degeneration with slow eye movements (nine families).

  1971cited by this paper

• Autoimmune cerebellar ataxia: An overlooked, but treatable, neuroimmune condition

  2025cites this paper
• Serum glutamate decarboxylase antibodies and neurological disorders: when to suspect their association?

  2021cites this paper
• Autoimmune Thyroid Disease Presenting as Ataxia

  2020cites this paper
• Autoimmune Vestibulocerebellar Syndromes

  2020cites this paper
• The neurological syndromes associated with glutamic acid decarboxylase antibodies.

  2019cites this paper
• Reduction of Total Brain and Cerebellum Volumes Associated With Neuronal Autoantibodies in Patients With APECED

  2018cites this paper
• Neurologic Manifestations of Systemic Disease ( N Scolding , C Rice and A Wilkins

  2017cites this paper
• Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review

  2017cites this paper
• Opsoclonus in a patient with increased titers of anti-GAD antibody provides proof for the conductance-based model of saccadic oscillations.

  2016cites this paper
• Síndromes atáxicos. Ataxias heredodegenerativas

  2015cites this paper
• Treatment of Paraneoplastic Cerebellar Degeneration

  2013cites this paper
• From anti-GAD to ataxia with ocular motor apraxia type 2: through the looking glass

  2013influential citation
• Cerebellar Ataxia from Multiple Potential Causes: Hypothyroidism, Hashimoto's Thyroiditis, Thalamic Stimulation, and Essential Tremor

  2012cites this paper
• Clinical presentation of immune-mediated cerebellar ataxia.

  2011cites this paper
• Autoimmune limbic encephalitis

  2011cites this paper
• [A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibody].

  2010cites this paper
• GAD antibodies associated neurological disorders: incidence and phenotype distribution among neurological inflammatory diseases.

  2010cites this paper
• Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems

  2009cites this paper
• The neurology of eye movements

  2009cites this paper
• Ophthalmoplegia a and D Downbeat N Nystagmus iin S Stiff-Person S Syndrome

  2009cites this paper
• Reversibility of cerebellar GABAergic synapse impairment induced by anti-glutamic acid decarboxylase autoantibodies.

  2008cites this paper
• Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies

  2008cites this paper
• 甲状腺機能正常な"橋本病"にともなう進行性小脳性運動失調症の臨床的検討∼小脳性運動失調における橋本病の自己抗体の関わりについて∼

  2008cites this paper
• [Steroid treatment in four cases of anti-GAD cerebellar ataxia].

  2008cites this paper
• [Progressive cerebellar ataxia with euthyroid Hashimoto's disease--implication of autoantibodies associated with Hashimoto's disease in progressive cerebellar ataxia].

  2008cites this paper
• Disorders of the Cerebellum, Including the Degenerative Ataxias

  2008cites this paper
• The relationship between alcoholic cerebellar degeneration and cognitive and emotional functioning.

  2008cites this paper
• Cerebellar ataxia associated with anti-glutamic acid decarboxylase autoantibodies

  2008cites this paper
• Autoantibody-mediated disorders of the central nervous system

  2008cites this paper
• Síndromes atáxicos. Ataxias heredodegenerativas y adquiridas.

  2007cites this paper
• Antibodies to GAD65 and peripheral nerve function in the DCCT.

  2007cites this paper
• [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].

  2006cites this paper
• Un nouveau cas d'ataxie cérébelleuse à anticorps anti-GAD traité par corticoïdes et initialement séronégatif

  2006cites this paper
• A rare saccade velocity profile in Stiff-Person Syndrome with cerebellar degeneration.

  2006cites this paper
• Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction.

  2006cites this paper
• Analysis of GAD65 Autoantibodies in Stiff-Person Syndrome Patients1

  2005cites this paper
• Stiff-Person Syndrome Patients Analysis of GAD 65 Autoantibodies in and

  2005cites this paper
• Anti-GAD antibodies and periodic alternating nystagmus.

  2005cites this paper
• Potential Role of Anti‐GAD Antibodies in Abnormal Eye Movements

  2005cites this paper
• Antigenic differences between neurological and diabetic patients with anti‐glutamic acid decarboxylase antibodies

  2005cites this paper
• Rol del glutamato y del sistema inmune en afecciones agudas y crónicas del SNC

  2005cites this paper
• The spectrum of antineuronal autoantibodies in a series of neurological patients.

  2004cites this paper
• Dual impairment of GABAA- and GABAB-receptor-mediated synaptic responses by autoantibodies to glutamic acid decarboxylase.

  2003cites this paper
• An investigation of the humoral immune response in patients with gluten ataxia.

  2003cites this paper
• [Clinical presentation of immune mediated cerebellar ataxia].

  2003cites this paper
• Glutamic acid decarboxylase autoantibodies and neurological disorders

  2002cites this paper
• T‐cell reactivity to glutamic acid decarboxylase in stiff‐man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity

  2002cites this paper
• Cerebellar degeneration and polyglandular autoimmune syndrome with anti-glutamic acid decarboxylase antibodies

  2002cites this paper
• Stiff man syndrome and related conditions

  2002cites this paper
• Clinical Presentation and Mechanisms of Immune-Mediated Cerebellar Ataxia

  2002cites this paper
• Ataxia associated with Hashimoto's disease: progressive non-familial adult onset cerebellar degeneration with autoimmune thyroiditis

  2001cites this paper
• Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer.

  2001cites this paper
• Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases

  2001cites this paper
• Cerebellar Ataxia Associated with High Levels of Anti-Glutamic Acid Decarboxylase Antibodies

  2001cites this paper
• Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.

  2001cites this paper
• Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase.

  2000cites this paper
• Antibodies to squalene in Gulf War syndrome.

  2000cites this paper
• [Anti-neuronal antibodies and central nervous system diseases: contribution to diagnosis and pathophysiology].

  2000cites this paper
• Humoral Immunity Against Glutamic Acid Decarboxylase and Tyrosine Phosphatase IA-2 in Lambert–Eaton Myasthenic Syndrome

  2000cites this paper
• Movement disorders of autoimmune origin

  1999cites this paper
• Phosphorus and proton magnetic resonance spectroscopy in episodic ataxia type 2

  1999cites this paper
• Cerebellar ataxia with glutamic acid decarboxylase autoantibodies

  1999cites this paper
• Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase

  1999cites this paper
• Spinocerebellar ataxia type 6: Evidence for a strong founder effect among German families

  1999cites this paper
• Stiff‐leg syndrome: A focal form of stiff‐man syndrome

  1998cites this paper
• Primary position upbeat nystagmus due to unilateral medial medullary infarction

  1998cites this paper
• Buspirone, a serotonergic 5-HT1A agonist, is active in cerebellar ataxia. A new fact in favor of the serotonergic theory of ataxia.

  1997cites this paper
• Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity

  1997cites this paper
• International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology.

  1997cites this paper
• Buspirone, a 5-hydroxytryptamine1A agonist, is active in cerebellar ataxia. Results of a double-blind drug placebo study in patients with cerebellar cortical atrophy.

  1997cites this paper
• Anti-GAD Antibody in Various Neurological Diseases

  1996cites this paper
• The insulin-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff-man syndrome patients.

  1996cites this paper
• Disease, transplantation and regeneration

  1996cites this paper
• Treatment of cerebellar ataxia with buspirone: a double-blind study.

  1996cites this paper